US Stock MarketDetailed Quotes

Kyverna Therapeutics (KYTX)

Watchlist

9.470
+0.260+2.82%

Close May 6 16:00 ET

9.700
+0.230+2.43%

Pre 04:33 ET

573.22MMarket Cap-2.60P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kyverna Therapeutics (KYTX) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-34.54%-153.71M

9.54%-33.53M

-57.59%-43.32M

-32.16%-31.95M

-75.96%-44.92M

-117.99%-114.25M

-99.65%-37.06M

-146.94%-27.49M

-114.76%-24.18M

-122.77%-25.53M

Net income from continuing operations

-26.54%-161.31M

-0.84%-37.8M

-6.65%-36.79M

-46.10%-42.08M

-67.22%-44.64M

-111.17%-127.48M

-81.40%-37.49M

-123.03%-34.49M

-120.02%-28.8M

-139.55%-26.69M

Operating gains losses

--60K

--20K

----

Depreciation and amortization

-15.66%1.8M

-34.64%368K

-25.63%415K

-2.83%515K

3.94%501K

24.96%2.13M

21.86%563K

27.40%558K

28.33%530K

22.34%482K

Other non cash items

16.82%2.97M

19.85%821K

8.93%732K

8.17%715K

33.84%704K

47.91%2.54M

50.88%685K

51.35%672K

50.91%661K

36.98%526K

Change In working capital

-113.69%-1.08M

5,000.00%1.73M

-268.53%-8.85M

86.64%8.23M

-18.82%-2.18M

129.47%7.86M

-96.63%34K

55.88%5.25M

734.85%4.41M

-23.94%-1.84M

-Change in prepaid assets

159.49%893K

106.95%58K

5.33%-1.14M

-24.32%2.35M

85.23%-380K

-25.92%-1.5M

15.23%-835K

-273.55%-1.2M

521.14%3.11M

-1,498.14%-2.57M

-Change in payables and accrued expense

-82.86%2.35M

-26.52%2.04M

-180.41%-5.98M

239.64%6.62M

-121.06%-326K

68.37%13.71M

-35.07%2.77M

126.06%7.44M

72.72%1.95M

383.52%1.55M

-Change in other current assets

49.87%-980K

150.31%483K

-44.49%-958K

125.64%10K

-75.77%-515K

-5.73%-1.96M

47.02%-960K

-283.24%-663K

-106.83%-39K

32.64%-293K

-Change in other current liabilities

-39.18%-3.34M

10.50%-844K

-138.15%-774K

-24.06%-758K

-85.19%-963K

-42.88%-2.4M

-103.67%-943K

26.30%-325K

-40.78%-611K

-52.49%-520K

Cash from discontinued investing activities

Operating cash flow

-34.54%-153.71M

9.54%-33.53M

-57.59%-43.32M

-32.16%-31.95M

-75.96%-44.92M

-117.99%-114.25M

-99.65%-37.06M

-146.94%-27.49M

-114.76%-24.18M

-122.77%-25.53M

Investing cash flow

Cash flow from continuing investing activities

124.87%40.02M

-159.16%-17.29M

3,236.83%22.56M

142.94%29.17M

104.54%5.58M

-1,731.55%-160.9M

-7.76%29.22M

101.25%676K

-2,263,933.33%-67.92M

-999.88%-122.88M

Capital expenditure reported

---1.13M

---538K

---390K

----

--0

----

Net PPE purchase and sale

102.95%65K

100.19%1K

166.67%68K

99.61%-4K

--0

-255.07%-2.21M

-59.28%-532K

60.16%-102K

-34,166.67%-1.03M

-1,839.29%-543K

Net investment purchase and sale

125.88%41.08M

-156.29%-16.75M

2,840.75%22.88M

143.91%29.37M

104.56%5.58M

-1,843.86%-158.7M

-7.06%29.75M

101.44%778K

---66.89M

-994.07%-122.34M

Cash from discontinued investing activities

Investing cash flow

124.87%40.02M

-159.16%-17.29M

3,236.83%22.56M

142.94%29.17M

104.54%5.58M

-1,731.55%-160.9M

-7.76%29.22M

101.25%676K

-2,263,933.33%-67.92M

-999.88%-122.88M

Financing cash flow

Cash flow from continuing financing activities

-58.12%141.17M

65,561.86%140.74M

1,078.95%1.49M

-14.06%-649K

-100.12%-414K

480.05%337.11M

85.01%-215K

-100.44%-152K

-102.28%-569K

234,856.25%338.05M

Net issuance payments of debt

15.48%-808K

65.59%-85K

50.41%-120K

-11.02%-262K

-47.62%-341K

-22.41%-956K

-12.79%-247K

-18.05%-242K

-24.87%-236K

-37.50%-231K

Net common stock issuance

-66.03%115.91M

--115.91M

--0

--341.17M

--0

--341.17M

Net preferred stock issuance

--24.7M

----

--0

----

Proceeds from stock option exercised by employees

667.18%1.99M

940.63%333K

1,734.44%1.65M

--0

-95.31%3K

-59.84%259K

-88.36%32K

-70.97%90K

102.78%73K

166.67%64K

Net other financing activities

81.58%-619K

---113K

---43K

4.68%-387K

97.43%-76K

-104.19%-3.36M

--0

---406K

---2.96M

Cash from discontinued financing activities

Financing cash flow

-58.12%141.17M

65,561.86%140.74M

1,078.95%1.49M

-14.06%-649K

-100.12%-414K

480.05%337.11M

85.01%-215K

-100.44%-152K

-102.28%-569K

234,856.25%338.05M

Net cash flow

Beginning cash position

175.97%97.17M

-67.01%34.72M

-59.16%53.99M

-74.46%57.42M

175.97%97.17M

-8.04%35.21M

347.24%105.23M

144.85%132.19M

457.38%224.86M

-8.04%35.21M

Current changes in cash

-55.66%27.47M

1,216.58%89.93M

28.51%-19.28M

96.30%-3.43M

-120.96%-39.75M

2,113.68%61.96M

-168.93%-8.05M

11.47%-26.97M

-779.06%-92.67M

9,137.46%189.65M

End cash Position

28.27%124.64M

-67.01%34.72M

-59.16%53.99M

-74.46%57.42M

175.97%97.17M

347.24%105.23M

144.85%132.19M

457.38%224.86M

Free cash flow

-32.97%-154.85M

9.39%-34.06M

-58.43%-43.71M

-27.58%-32.15M

-72.30%-44.92M

-119.60%-116.46M

-98.94%-37.59M

-142.28%-27.59M

-123.83%-25.2M

-126.95%-26.07M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-34.54%-153.71M	9.54%-33.53M	-57.59%-43.32M	-32.16%-31.95M	-75.96%-44.92M	-117.99%-114.25M	-99.65%-37.06M	-146.94%-27.49M	-114.76%-24.18M	-122.77%-25.53M
Net income from continuing operations	-26.54%-161.31M	-0.84%-37.8M	-6.65%-36.79M	-46.10%-42.08M	-67.22%-44.64M	-111.17%-127.48M	-81.40%-37.49M	-123.03%-34.49M	-120.02%-28.8M	-139.55%-26.69M
Operating gains losses	--60K	--20K	----	----	----	----	----	----	----	----
Depreciation and amortization	-15.66%1.8M	-34.64%368K	-25.63%415K	-2.83%515K	3.94%501K	24.96%2.13M	21.86%563K	27.40%558K	28.33%530K	22.34%482K
Other non cash items	16.82%2.97M	19.85%821K	8.93%732K	8.17%715K	33.84%704K	47.91%2.54M	50.88%685K	51.35%672K	50.91%661K	36.98%526K
Change In working capital	-113.69%-1.08M	5,000.00%1.73M	-268.53%-8.85M	86.64%8.23M	-18.82%-2.18M	129.47%7.86M	-96.63%34K	55.88%5.25M	734.85%4.41M	-23.94%-1.84M
-Change in prepaid assets	159.49%893K	106.95%58K	5.33%-1.14M	-24.32%2.35M	85.23%-380K	-25.92%-1.5M	15.23%-835K	-273.55%-1.2M	521.14%3.11M	-1,498.14%-2.57M
-Change in payables and accrued expense	-82.86%2.35M	-26.52%2.04M	-180.41%-5.98M	239.64%6.62M	-121.06%-326K	68.37%13.71M	-35.07%2.77M	126.06%7.44M	72.72%1.95M	383.52%1.55M
-Change in other current assets	49.87%-980K	150.31%483K	-44.49%-958K	125.64%10K	-75.77%-515K	-5.73%-1.96M	47.02%-960K	-283.24%-663K	-106.83%-39K	32.64%-293K
-Change in other current liabilities	-39.18%-3.34M	10.50%-844K	-138.15%-774K	-24.06%-758K	-85.19%-963K	-42.88%-2.4M	-103.67%-943K	26.30%-325K	-40.78%-611K	-52.49%-520K
Cash from discontinued investing activities
Operating cash flow	-34.54%-153.71M	9.54%-33.53M	-57.59%-43.32M	-32.16%-31.95M	-75.96%-44.92M	-117.99%-114.25M	-99.65%-37.06M	-146.94%-27.49M	-114.76%-24.18M	-122.77%-25.53M
Investing cash flow
Cash flow from continuing investing activities	124.87%40.02M	-159.16%-17.29M	3,236.83%22.56M	142.94%29.17M	104.54%5.58M	-1,731.55%-160.9M	-7.76%29.22M	101.25%676K	-2,263,933.33%-67.92M	-999.88%-122.88M
Capital expenditure reported	---1.13M	---538K	---390K	----	----	--0	--0	--0	----	----
Net PPE purchase and sale	102.95%65K	100.19%1K	166.67%68K	99.61%-4K	--0	-255.07%-2.21M	-59.28%-532K	60.16%-102K	-34,166.67%-1.03M	-1,839.29%-543K
Net investment purchase and sale	125.88%41.08M	-156.29%-16.75M	2,840.75%22.88M	143.91%29.37M	104.56%5.58M	-1,843.86%-158.7M	-7.06%29.75M	101.44%778K	---66.89M	-994.07%-122.34M
Cash from discontinued investing activities
Investing cash flow	124.87%40.02M	-159.16%-17.29M	3,236.83%22.56M	142.94%29.17M	104.54%5.58M	-1,731.55%-160.9M	-7.76%29.22M	101.25%676K	-2,263,933.33%-67.92M	-999.88%-122.88M
Financing cash flow
Cash flow from continuing financing activities	-58.12%141.17M	65,561.86%140.74M	1,078.95%1.49M	-14.06%-649K	-100.12%-414K	480.05%337.11M	85.01%-215K	-100.44%-152K	-102.28%-569K	234,856.25%338.05M
Net issuance payments of debt	15.48%-808K	65.59%-85K	50.41%-120K	-11.02%-262K	-47.62%-341K	-22.41%-956K	-12.79%-247K	-18.05%-242K	-24.87%-236K	-37.50%-231K
Net common stock issuance	-66.03%115.91M	--115.91M	--0	--0	--0	--341.17M	--0	--0	--0	--341.17M
Net preferred stock issuance	--24.7M	----	----	----	----	--0	--0	--0	----	----
Proceeds from stock option exercised by employees	667.18%1.99M	940.63%333K	1,734.44%1.65M	--0	-95.31%3K	-59.84%259K	-88.36%32K	-70.97%90K	102.78%73K	166.67%64K
Net other financing activities	81.58%-619K	---113K	---43K	4.68%-387K	97.43%-76K	-104.19%-3.36M	--0	--0	---406K	---2.96M
Cash from discontinued financing activities
Financing cash flow	-58.12%141.17M	65,561.86%140.74M	1,078.95%1.49M	-14.06%-649K	-100.12%-414K	480.05%337.11M	85.01%-215K	-100.44%-152K	-102.28%-569K	234,856.25%338.05M
Net cash flow
Beginning cash position	175.97%97.17M	-67.01%34.72M	-59.16%53.99M	-74.46%57.42M	175.97%97.17M	-8.04%35.21M	347.24%105.23M	144.85%132.19M	457.38%224.86M	-8.04%35.21M
Current changes in cash	-55.66%27.47M	1,216.58%89.93M	28.51%-19.28M	96.30%-3.43M	-120.96%-39.75M	2,113.68%61.96M	-168.93%-8.05M	11.47%-26.97M	-779.06%-92.67M	9,137.46%189.65M
End cash Position	28.27%124.64M	28.27%124.64M	-67.01%34.72M	-59.16%53.99M	-74.46%57.42M	175.97%97.17M	175.97%97.17M	347.24%105.23M	144.85%132.19M	457.38%224.86M
Free cash flow	-32.97%-154.85M	9.39%-34.06M	-58.43%-43.71M	-27.58%-32.15M	-72.30%-44.92M	-119.60%-116.46M	-98.94%-37.59M	-142.28%-27.59M	-123.83%-25.2M	-126.95%-26.07M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm